We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Automated Phone Speech Test Identifies Alzheimer’s Pathology for Prescreening

By HospiMedica International staff writers
Posted on 22 May 2026

Alzheimer’s disease assessment and trial recruitment often rely on costly, invasive biomarker testing and clinic-based cognitive evaluations, limiting scalability as populations age. More...

Providers and trial sponsors need remote tools that can help triage candidates and monitor cognition without requiring in-person visits. A new automated, phone-based speech biomarker now offers a scalable approach for detecting cognitive impairment and signals of underlying Alzheimer’s pathology across multiple languages.

ki:elements’ (Saarbrücken, Germany) Speech Biomarker for Cognition (SB-C) was evaluated in peer-reviewed research conducted with the PROSPECT-AD consortium. The assessment is delivered via the Mili platform, which places a phone call to participants at home and administers a 10-minute task through an AI voice agent. The study enrolled 736 participants across five independent cohorts in Spain, the UK, Germany, and Sweden.

SB-C analyzes 70 distinct speech features to index cognitive efficiency and generate an automatic biomarker score. The approach distinguished cognitively unimpaired individuals from those with mild cognitive impairment (MCI) or early dementia and classified cerebrospinal fluid biomarker status remotely. Performance included identification of amyloid-beta positivity with an AUC of up to 0.74 and phosphorylated tau 181 positivity with an AUC of up to 0.82.

The tool showed multilingual sensitivity across Spanish, Catalan, German, English, and Swedish. It demonstrated strong convergent validity with established measures such as MMSE and PACC-5 and is validated following the Digital Medicine Society’s V3 Framework. It is currently deployed as a pre-screening tool in multiple Alzheimer’s disease clinical trials to enrich for biomarker‑positive participants prior to invasive testing.

“This study gives us real-world, multi-site evidence that a speech assessment can track with established cognitive measures and distinguish patients by their underlying pathology. For sponsors, this translates directly into faster, smarter recruitment, and a lower-burden tool for participants,” said Dr. Alexandra König, Chief Clinical Research Officer of ki:elements and corresponding author of the study.

Related Links
ki:elements


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Gold Member
12-Channel ECG
CM1200B
Radiofrequency Generator
GX1
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.